September 26, 2024 09:00 PM EDTUpdated 01:03 PM
Startups
Special

End­points 11 win­ner Met­sera: Clive Mean­well wa­gers on obe­si­ty af­ter Med­i­cines Com­pa­ny suc­cess

Kyle LaHucik

Senior Reporter

↑
  • CEO Clive Mean­well
  • To­tal raised $290 mil­lion
  • Head­quar­ters New York, NY

Short­ly af­ter Clive Mean­well sold The Med­i­cines Com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Will CRISPR mat­ter?

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times